<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for SB 636          </title>
<shortdesc>PHARMACY-DIALYSIS DRUGS</shortdesc>
<sponsor>
<sponsorhead1>Senate Sponsors</sponsorhead1><sponsors>Sen. Terry Link-Melinda Bush</sponsors>
<sponsorhead2>House Sponsors</sponsorhead2><altsponsors>(Rep. Rita Mayfield-Patricia R. Bellock-Barbara Wheeler-Terri Bryant)</altsponsors>
</sponsor>
<lastaction>
<statusdate>8/18/2017</statusdate><chamber>Senate</chamber><action>Public Act . . . . . . . . . 100-0218</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>225 ILCS 85/4</reference><aliasreference>from Ch. 111, par. 4124</aliasreference><SynopsisText>Amends the Pharmacy Practice Act. Provides that the Act shall not apply to, or in any manner interfere with, the sale or distribution of dialysate, drugs, or devices necessary to perform home renal dialysis for patients with chronic kidney failure, provided that certain conditions are met. Effective immediately.</SynopsisText><synopsistitle>Senate Floor Amendment No. 2</synopsistitle>
<SynopsisText>Replaces everything after the enacting clause. Reinserts the introduced bill with the following changes: Provides that the exemption applies to dialysate or devices (rather than dialysate, drugs, or devices) necessary to perform home peritoneal renal dialysis for patients with end-stage renal disease, provided that certain conditions are met. Provides that among the conditions, the dialysate is comprised of dextrose or icodextrin and that the dialysate or devices are delivered only upon receipt of a physician's prescription by a licensed pharmacy in which the prescription is processed in accordance with provisions set forth in the Act, and the transmittal of an order from the licensed pharmacy to the manufacturer or the manufacturer's agent (rather than the dialysate, drugs, or devices are delivered only by the manufacturer or the manufacturer's agent and only upon receipt of a physician's order). Provides that the exemption does not include any other drugs for peritoneal dialysis, except dialysate comprised of dextrose or icodextrin. Provides that all records of sales and distributions of dialysate to patients made pursuant to the provisions must be retained in accordance with provisions concerning record retention in the Act.</SynopsisText></synopsis>
<actions>
<statusdate>1/25/2017</statusdate><chamber>Senate</chamber><action>Filed with Secretary by Sen. Terry Link</action>
<statusdate>1/25/2017</statusdate><chamber>Senate</chamber><action>First Reading</action>
<statusdate>1/25/2017</statusdate><chamber>Senate</chamber><action>Referred to Assignments</action>
<statusdate>2/1/2017</statusdate><chamber>Senate</chamber><action>Assigned to Licensed Activities and Pensions</action>
<statusdate>2/16/2017</statusdate><chamber>Senate</chamber><action>Postponed - Licensed Activities and Pensions</action>
<statusdate>2/28/2017</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Filed with Secretary by Sen. Terry Link</action>
<statusdate>2/28/2017</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Referred to Assignments</action>
<statusdate>3/1/2017</statusdate><chamber>Senate</chamber><action>Do Pass Licensed Activities and Pensions;  011-000-000</action>
<statusdate>3/1/2017</statusdate><chamber>Senate</chamber><action>Placed on Calendar Order of 2nd Reading March 2, 2017</action>
<statusdate>3/1/2017</statusdate><chamber>Senate</chamber><action>Added as Chief Co-Sponsor Sen. Melinda Bush</action>
<statusdate>3/7/2017</statusdate><chamber>Senate</chamber><action>Senate Floor Amendment No. 2 Filed with Secretary by Sen. Terry Link</action>
<statusdate>3/7/2017</statusdate><chamber>Senate</chamber><action>Senate Floor Amendment No. 2 Referred to Assignments</action>
<statusdate>3/8/2017</statusdate><chamber>Senate</chamber><action>Senate Floor Amendment No. 2 Assignments Refers to Licensed Activities and Pensions</action>
<statusdate>3/16/2017</statusdate><chamber>Senate</chamber><action>Senate Floor Amendment No. 2 Recommend Do Adopt Licensed Activities and Pensions;  011-000-000</action>
<statusdate>4/25/2017</statusdate><chamber>Senate</chamber><action>Second Reading</action>
<statusdate>4/25/2017</statusdate><chamber>Senate</chamber><action>Senate Floor Amendment No. 2 Adopted; Link</action>
<statusdate>4/25/2017</statusdate><chamber>Senate</chamber><action>Placed on Calendar Order of 3rd Reading April 26, 2017</action>
<statusdate>4/28/2017</statusdate><chamber>Senate</chamber><action>Rule 2-10 Third Reading Deadline Established As May 31, 2017</action>
<statusdate>5/3/2017</statusdate><chamber>Senate</chamber><action>Third Reading - Passed; 056-000-000</action>
<statusdate>5/3/2017</statusdate><chamber>Senate</chamber><action>Senate Committee Amendment No. 1 Tabled Pursuant to Rule 5-4(a)</action>
<statusdate>5/3/2017</statusdate><chamber>House</chamber><action>Arrived in House</action>
<statusdate>5/3/2017</statusdate><chamber>House</chamber><action>Chief House Sponsor Rep. Rita Mayfield</action>
<statusdate>5/9/2017</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>5/9/2017</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>5/15/2017</statusdate><chamber>House</chamber><action>Assigned to Health Care Licenses Committee</action>
<statusdate>5/19/2017</statusdate><chamber>House</chamber><action>Committee Deadline Extended-Rule 9(b) May 26, 2017</action>
<statusdate>5/24/2017</statusdate><chamber>House</chamber><action>Do Pass / Short Debate Health Care Licenses Committee;  015-000-000</action>
<statusdate>5/24/2017</statusdate><chamber>House</chamber><action>Placed on Calendar 2nd Reading - Short Debate</action>
<statusdate>5/24/2017</statusdate><chamber>House</chamber><action>Second Reading - Short Debate</action>
<statusdate>5/24/2017</statusdate><chamber>House</chamber><action>Placed on Calendar Order of 3rd Reading - Short Debate</action>
<statusdate>5/26/2017</statusdate><chamber>House</chamber><action>Third Reading - Short Debate - Passed 113-000-000</action>
<statusdate>5/26/2017</statusdate><chamber>House</chamber><action>Added Alternate Chief Co-Sponsor Rep. Patricia R. Bellock</action>
<statusdate>5/26/2017</statusdate><chamber>House</chamber><action>Added Alternate Chief Co-Sponsor Rep. Barbara Wheeler</action>
<statusdate>5/26/2017</statusdate><chamber>House</chamber><action>Added Alternate Chief Co-Sponsor Rep. Terri Bryant</action>
<statusdate>5/26/2017</statusdate><chamber>Senate</chamber><action>Passed Both Houses</action>
<statusdate>6/23/2017</statusdate><chamber>Senate</chamber><action>Sent to the Governor</action>
<statusdate>8/18/2017</statusdate><chamber>Senate</chamber><action>Governor Approved</action>
<statusdate>8/18/2017</statusdate><chamber>Senate</chamber><action>Effective Date August 18, 2017</action>
<statusdate>8/18/2017</statusdate><chamber>Senate</chamber><action>Public Act . . . . . . . . . 100-0218</action>
</actions>
</xml>

